Fazio S - Search Results

1

PCSK9: From Basic Science Discoveries to Clinical Trials.

Shapiro MD, Tavori H, Fazio S. Shapiro MD, et al. Among authors: fazio s. Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227. Circ Res. 2018. PMID: 29748367 Free PMC article. Review.

2

Current perspectives on statins.

Maron DJ, Fazio S, Linton MF. Maron DJ, et al. Among authors: fazio s. Circulation. 2000 Jan 18;101(2):207-13. doi: 10.1161/01.cir.101.2.207. Circulation. 2000. PMID: 10637210 Review.

3

Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.

Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF. Zhang W, et al. Among authors: fazio s. Circulation. 2003 Nov 4;108(18):2258-63. doi: 10.1161/01.CIR.0000093189.97429.9D. Epub 2003 Oct 27. Circulation. 2003. PMID: 14581413

4

Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.

Su YR, Dove DE, Major AS, Hasty AH, Boone B, Linton MF, Fazio S. Su YR, et al. Among authors: fazio s. Circulation. 2005 May 10;111(18):2373-81. doi: 10.1161/01.CIR.0000164236.19860.13. Epub 2005 Apr 25. Circulation. 2005. PMID: 15851589

5

Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse.

Overton CD, Yancey PG, Major AS, Linton MF, Fazio S. Overton CD, et al. Among authors: fazio s. Circ Res. 2007 Mar 16;100(5):670-7. doi: 10.1161/01.RES.0000260204.40510.aa. Epub 2007 Feb 15. Circ Res. 2007. PMID: 17303763

6

Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase.

Gustafsson M, Levin M, Skålén K, Perman J, Fridén V, Jirholt P, Olofsson SO, Fazio S, Linton MF, Semenkovich CF, Olivecrona G, Borén J. Gustafsson M, et al. Among authors: fazio s. Circ Res. 2007 Oct 12;101(8):777-83. doi: 10.1161/CIRCRESAHA.107.149666. Epub 2007 Aug 30. Circ Res. 2007. PMID: 17761930

7

More clinical lessons from the FIELD study.

Fazio S. Fazio S. Cardiovasc Drugs Ther. 2009 Jun;23(3):235-41. doi: 10.1007/s10557-008-6160-5. Cardiovasc Drugs Ther. 2009. PMID: 19160032 Review.

8

Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.

Yancey PG, Ding Y, Fan D, Blakemore JL, Zhang Y, Ding L, Zhang J, Linton MF, Fazio S. Yancey PG, et al. Among authors: fazio s. Circulation. 2011 Jul 26;124(4):454-64. doi: 10.1161/CIRCULATIONAHA.111.032268. Epub 2011 Jul 5. Circulation. 2011. PMID: 21730304 Free PMC article.

9

Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.

Tavori H, Fan D, Blakemore JL, Yancey PG, Ding L, Linton MF, Fazio S. Tavori H, et al. Among authors: fazio s. Circulation. 2013 Jun 18;127(24):2403-13. doi: 10.1161/CIRCULATIONAHA.113.001592. Epub 2013 May 20. Circulation. 2013. PMID: 23690465 Free PMC article.

10

Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis.

Tavori H, Giunzioni I, Linton MF, Fazio S. Tavori H, et al. Among authors: fazio s. Circ Res. 2013 Dec 6;113(12):1290-5. doi: 10.1161/CIRCRESAHA.113.302655. Epub 2013 Oct 11. Circ Res. 2013. PMID: 24122718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results